featured-image

NASHVILLE, Tenn.--(BUSINESS WIRE)--Nov 20, 2024-- In a strategic move to elevate thought leadership and strengthen market differentiation, Bailey & Company announced today the appointment of Rebecca Springer, Ph.D.

, former lead healthcare analyst at PitchBook, as director of market development. This addition marks a significant step in the Bailey & Company’s growth strategy, reinforcing the firm’s commitment to excellence in middle market healthcare advisory. This press release features multimedia.



View the full release here: https://www.businesswire.com/news/home/20241120083373/en/ Bailey & Company announced today the appointment of Rebecca Springer, Ph.

D., former lead healthcare analyst at PitchBook, as director of market development. (Photo: Business Wire) Springer brings a wealth of expertise in healthcare, life sciences, and private equity industry research across multiple sectors.

Her own research spans healthcare services, healthcare IT, and pharmaceutical services. Springer has also served as an authoritative market voice for a wide readership of private equity investors, advisors, strategic investors, and other participants in the middle market healthcare ecosystem. “Rebecca’s industry expertise and academic background offer our clients a unique lens into how market trends and regulations are impacting growth and value," said Bailey & Company CEO Tim Scallen.

"Her expertise in proactively identifying high-potential subsector trends and translating them into a.

Back to Health Page